Recall of clobetasol propionate cream over content uniformity failure in the United States

Several tubes of clobetasol propionate cream have been voluntarily recalled in the US after the product failed to meet content uniformity specifications. The affected batch was manufactured in India, and the recall has been classified as Class II, indicating potential but generally temporary or reversible health risks. The recall highlights the importance of robust quality-control systems and content uniformity testing for pharmaceutical products manufactured in India for export markets.